top of page
Actorius Innovations & Research logo
Contact
Abstract blue-green gradient with translucent cell-like circle

From cell
to certainty.

Transforming cellular discoveries into breakthrough technologies that advance cancer research, deepen our understanding of metastasis, and shape the future of oncology.

Know More

OncoMetastat®

OncoMetastat® is an extracorporeal blood-processing platform engineered to selectively capture and deplete circulating tumor cells — designed to delay cancer metastasis in early stage cancers.

Book a demo

We are in pursuit of identifying and developing life-saving solutions for global healthcare problems with a focus on cancer diagnostics and cure.

Trusted by:
AQTREC logo
All India Institute of Medical Sciences seal
Tata Memorial Hospital Mumbai logo, Service, Research, Education
Tata Memorial Centre logo with medical cross, Service Research Education
MAX Healthcare logo
HCG Hospitals logo, adding life to years
Apollo Hospitals logo
Fortis logo
GeminiGenerated_Image_nzs47ynzs47ynzs4_edited.jpg

Why choose us?

Our approach is grounded in rigorous research, advanced platforms, and a commitment to meaningful outcomes.

11000+

Patients Served Globally

450+

Doctors Trust Us

100+

Publications

13+

Years of Excellence

Patented Techologies

Proprietary innovations designed to deliver precision, reliability, and real-world impact.

Regulatory Approved

Regulatory-approved solutions built to meet the highest standards of safety, compliance, and clinical integrity.

Our Publications

More than 100+ publications in

ASCO, AACR, ESMO, ISLB, etc

Read our publications
ASCO American Society of Clinical Oncology logo
Green R symbol with horizontal bar
ISLB logo for International Society of Liquid Biopsy
ESMO logo: Good Science, Better Medicine, Best Practice

Latest from Actorius

Explore the latest updates, research perspectives, announcements, and stories shaping our work.

View all updates

The Hidden Threat of a Single Cell: Dr. Jayant Khandare on How One Circulating Tumor Cell Can Restart the Cancer Journey

May 24, 2026

Read More

ASCO 2026 : Association of circulating tumor cells with PD-L1 expression and clusters in confirmative tumor thrombus in selective solid cancers.

March 17, 2026

Read More

ASCO 26: Assessment of circulating tumor cells and clusters expressing PD-L1 in urological cancers

March 17, 2026

Read More

Actorius in Action

Stay updated with our latest events, scientific discussions, collaborations, and milestones that continue to shape the future of cancer research and innovation.

View all events
AACR 2026 - Actorius Innovations and Research

AACR 2026 Highlights | April 17-22 | San Diego, California

April 23, 2026

Read More
Meeting with Oncology KOLs in USA and Europe | Klaus Pantel , Catherine Alix, Umberto, Ravindra Kolhe

Meeting with our KOLs

February 20, 2026

Read More
Actorius ISLB 2025 | 1-3 November 2025

ISLB 2025 | 1-3 November 2025

November 3, 2025

Read More

In the News

Explore how OncoDiscover® is making headlines in cancer research and diagnostics.

View all mentions
The deadliest cancer threat may be invisible — just one surviving cell can be enough to restart the disease journey - Dr Jayant Khandare
May 24, 2026

The Hidden Threat of a Single Cell: Dr. Jayant Khandare on How One Circulating Tumor Cell Can Restart the Cancer Journey

The deadliest cancer threat may be invisible — just one surviving cell can be enough to restart the disease journey.

Read More
ANI News | Actorius Innovations and Research
March 17, 2026

Actorius Innovations pioneers' oncology care with its OncoDiscover and OncoMetastat solutions

Dr. Jayant Khandare Leads Actorius with Pathbreaking Innovations in Cancer Detection and Metastasis Control

Read More
Business Standards | Actorius Innovations and Research
March 17, 2026

Actorius Innovations pioneers' oncology care with its OncoDiscover and OncoMetastat solutions

Dr. Jayant Khandare Leads Actorius with Pathbreaking Innovations in Cancer Detection and Metastasis Control

Read More
© Copyright Actorius Innovations and Research

Frequently Asked Questions

Answers to commonly asked questions about Actorius and our offerings.

Know More
  • Actorius focuses on understanding cancer at the cellular level and translating that insight into precise, actionable outcomes. Our platforms are designed to look deeper, act earlier, and support more confident decisions.

  • Our solutions are built for clinicians, researchers, healthcare partners, and institutions seeking advanced tools for cancer detection, analysis, and monitoring.

  • We combine advanced biomaterials, biological insight, and data-driven analysis to study cancer behavior in detail—enabling earlier detection and more targeted intervention.

  • Our work spans both research and translational applications. Some solutions are designed for research use, while others are developed with clinical deployment in mind, subject to regulatory requirements.

  • You can explore our latest blogs, newsletters, press releases, case studies, and events in the Resources section to stay informed about our progress and insights.

bottom of page